Skip to main content

Table 1 Descriptive statistics of those accessing telehealth during COVID-19 (N = 22)

From: Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic

Characteristic

N (%)

Age (median, IQR)

35.5 (33–51)

Biological sex

 

 Male

14 (67)

 Female

7 (33)

Race/ethnicity

 

 White non-Hispanic

9 (43)

 Black non-Hispanic

4 (19)

 Hispanic

8 (38)

IDEA SSP participant

 

 Yes

11 (52)

 No

10 (48)

Current injection drug use

 

 Yes

10 (50)

 No

10 (50)

Substances injected (n = 10)

 

 Heroin

8 (80)

 Fentanyl

5 (50)

 Cocaine

2 (20)

 Other (ketamine)

1 (10)

Self-reported HIV status

 

 Positive

3 (14)

 Negative

16 (76)

 Unknown

2 (10)

Self-reported HCV status

 

 Positive

8 (38)

 Negative

10 (48)

 Unknown

3 (14)